These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration. Francesconi MA; Deana R; Girolami A; Pontara E; Casonato A Thromb Haemost; 1993 Oct; 70(4):697-701. PubMed ID: 8115999 [TBL] [Abstract][Full Text] [Related]
23. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation. Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154 [TBL] [Abstract][Full Text] [Related]
24. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5. Nakatanl S; Hato T; Minamoto Y; Fujita S Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028 [TBL] [Abstract][Full Text] [Related]
25. RGD-containing peptides inhibit adhesion of 293 cells transfected with GpIIb/IIIa to fibrinogen: comparison to inhibition of platelet aggregation. Fei DT; Lowe J; Bodary S; Bunting S; McLean JW; Napier M; Chen AB Blood Coagul Fibrinolysis; 1993 Apr; 4(2):255-62. PubMed ID: 8499563 [TBL] [Abstract][Full Text] [Related]
26. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms involved in platelet activation induced by a monoclonal antibody anti glycoprotein IIb-IIIa: inositol phosphate production is not the primary event. Bachelot C; Sulpice JC; Giraud F; Rendu F Cell Signal; 1991; 3(6):537-46. PubMed ID: 1786204 [TBL] [Abstract][Full Text] [Related]
28. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa. Schneider DJ; Taatjes DJ; Sobel BE Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364 [TBL] [Abstract][Full Text] [Related]
29. Effects of ATP on ligand recognition of platelet fibrinogen receptor on GPIIb-IIIa. Gawaz MP; Mayinger P; Neumann FJ Am J Physiol; 1994 Sep; 267(3 Pt 2):H1098-106. PubMed ID: 8092274 [TBL] [Abstract][Full Text] [Related]
30. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation. Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172 [TBL] [Abstract][Full Text] [Related]
31. Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. Ginsberg MH; Lightsey A; Kunicki TJ; Kaufmann A; Marguerie G; Plow EF J Clin Invest; 1986 Oct; 78(4):1103-11. PubMed ID: 2428841 [TBL] [Abstract][Full Text] [Related]
32. The mechanism of cold-induced platelet aggregation in the presence of heparin. Akiyama M; Takami H; Yoshida Y Tohoku J Exp Med; 1995 Dec; 177(4):365-74. PubMed ID: 8928196 [TBL] [Abstract][Full Text] [Related]
33. Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity. Jennings LK; White MM; Mandrell TD Thromb Haemost; 1995 Dec; 74(6):1551-6. PubMed ID: 8772236 [TBL] [Abstract][Full Text] [Related]
34. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. Golden A; Brugge JS; Shattil SJ J Cell Biol; 1990 Dec; 111(6 Pt 2):3117-27. PubMed ID: 1702789 [TBL] [Abstract][Full Text] [Related]
35. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation. Mohri H; Ohkubo T Am J Clin Pathol; 1991 Nov; 96(5):605-9. PubMed ID: 1719797 [TBL] [Abstract][Full Text] [Related]
36. Ligand interactions with the RGD recognition site alter binding of GPIIb-IIIa reactive monoclonal antibody to human platelets. Marder P Biochem Biophys Res Commun; 1993 Sep; 195(2):799-806. PubMed ID: 8373415 [TBL] [Abstract][Full Text] [Related]
37. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors. Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101 [TBL] [Abstract][Full Text] [Related]
38. The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. Jennings LK; Fox CF; Kouns WC; McKay CP; Ballou LR; Schultz HE J Biol Chem; 1990 Mar; 265(7):3815-22. PubMed ID: 2303480 [TBL] [Abstract][Full Text] [Related]
39. Stimulatory antibody-induced activation and selective translocation of protein kinase C isoenzymes in human platelets. Wang F; Naik UP; Ehrlich YH; Osada S; Ohno S; Kornecki E Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):401-6. PubMed ID: 7487874 [TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphorylation in human platelets during shear stress-induced platelet aggregation (SIPA) is regulated by glycoprotein (GP) Ib/IX as well as GP IIb/IIIa and requires intact cytoskeleton and endogenous ADP. Oda A; Yokoyama K; Murata M; Tokuhira M; Nakamura K; Handa M; Watanabe K; Ikeda Y Thromb Haemost; 1995 Aug; 74(2):736-42. PubMed ID: 8585015 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]